Cerephex

company

About

Cerephex offers RINCE, a technology for treatment applications involving non-invasive brain stimulation.

  • 51 - 100

Details

Last Funding Type
Series A
Last Funding Money Raised
$5.92M
Industries
Health Care,Medical,Medical Device
Founded date
Jan 1, 2012
Number Of Employee
51 - 100
Operating Status
Active

Cerephex is a company developing its proprietary RINCE technology for treatment applications involving noninvasive brain stimulation. Cerephex is currently engaged in development activities aimed at gaining FDA approval of its NeuroPoint device for the management of fibromyalgia, a chronic pain condition that involves abnormal central pain
processing mechanisms.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$5.92M
Cerephex has raised a total of $5.92M in funding over 2 rounds. Their latest funding was raised on Oct 12, 2012 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 12, 2012 Series A $5.92M 1 Versant Ventures Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Cerephex is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures Yes Series A